Degludec Shows Efficacy in Type 1 Diabetes (CME/CE)
PHOENIX (MedPage Today) -- Type 1 diabetes patients had lower rates of nocturnal hypoglycemia when receiving once-daily doses of insulin degludec compared with similar doses of insulin glargine, researchers reported here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 1 | Endocrinology | Heart | Insulin | Lantus